Japan· JP-2189019M1047
オメガ-3脂肪酸エチル
A medicinal product containing オメガ-3脂肪酸エチル, registered in Japan by 陽進堂ホールディングス, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- オメガ-3脂肪酸エチル
- Manufacturer
- 陽進堂ホールディングス
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
オメガ-3脂肪酸エチル in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyAGEMOISTITUTO BIOCHIMICO NAZIONALE SAVIO S.R.L.
- United StatesLovazaWaylis Therapeutics LLC
- PolandOmacorDelfarma Sp. z o.o.
- IrelandOmacor 1000 mg Soft CapsulesBASF AS
- NorwayOmacorBASF
- GermanyOmacorBasf As
- FranceOMACOR, capsule molleDIFARMED (ESPAGNE)
- BelgiumOmacor 1000 mgBASF
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Omacor, Zodin
- Belgium · Omacor
- Bulgaria · Омакор
- Cyprus · Omacor
- Germany · Omacor, Zodin
- Denmark · Lipomeg
- Estonia · Omacor
- Spain · Ácidos Omega-3 Strides, Omacor
- France · Esters Ethyliques D’acides Omega 3 Eg Labo Conseil, Esters Ethyliques D’acides Omega-3 Ibsa
- United Kingdom (Northern Ireland) · Omacor, Omega 3-Acid-Ethyl Esters Strides Pharma Uk
- Greece · Becolip, Lipemia Forte
- Croatia · Dualtis, Omacor
- Hungary · Omacor
- Ireland · Omacor, Trimega
- Italy · Agemo, Eskim
- Lithuania · Omacor
- Luxembourg · Omacor
- Latvia · Omacor
- Malta · Omacor
- Netherlands · Omacor
- Norway · Omacor
- Poland · Omacor
- Portugal · Ésteres Etílicos 90 Dos Ácidos Ómega-3 Pharmanel, Omacor
- Romania · Omacor
- Sweden · Lipomeg
- Slovenia · Omacor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/658d7257-59f7-47a5-b3f6-2bab98ffdfe0 GET /v1/drugs/658d7257-59f7-47a5-b3f6-2bab98ffdfe0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "2g1包",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2189019M1047",
"category": "内用薬",
"price_yen": 72.3,
"generic_name": "オメガ-3脂肪酸エチル",
"product_name_jp": null,
"therapeutic_class": "2189",
"transitional_expiry": null
}See everything about オメガ-3脂肪酸エチル.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.